Immucor Acquires BioArray Solutions
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
DCN Receives Growth Equity Investment from Martis Capital
TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital
Empirical Bioscience has been Acquired by Fortis Life Sciences
TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences
Neoteryx has been Acquired by Trajan Group
TM Capital served as exclusive financial advisor to Neoteryx, LLC in connection with its sale to Trajan Group Holdings Limited (Australian Stock Exchange: TRJ)